There’s a lot of fear around applying artificial intelligence to the life sciences.

And while Diogo Rau concedes that there are risks associated with using AI, the biggest risk is that we won’t use it.

Diogo Rau is EVP and Chief Information and Digital Officer of Eli Lilly & Company, where he leads their information technology, cybersecurity, digital health, advanced analytics and data science functions.

Prior to joining Lilly, Diogo served as Head of Engineering for Apple Retail and Partner at McKinsey & Company.

On this episode of The Beat, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world.

Diogo explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly.

Listen in for Diogo’s insight on using tech to inspire behavior change in patients and learn how we might leverage AI to generate new medicines, improve clinical trials and facilitate personalized medicine.

Topics Covered

How Diogo is bringing Apple’s focus on the end user to life sciences
Diogo’s take on what differentiates customers from patients
What inspired Diogo’s transition from Apple to his current role at Lilly
Leveraging artificial intelligence to facilitate personalized medicine
Why Lilly is prioritizing AI-designed and generated medicines
How to discern when we can innovate fast in the life sciences space
Building a culture of innovation in a large company like Lilly
How Diogo thinks about Lilly’s role in the healthcare ecosystem
Diogo’s vision of what an Apple-like healthcare experience looks like
Using technology to facilitate prevention through behavior change
Why Lilly is working on both insulin drugs and diabetes prevention
Diogo’s mission to impact the way medicine gets to patients

Connect with Diogo Rau

Eli Lilly & Company

Diogo on LinkedIn

Connect with Dr. Jessica Shepherd & Dr. Gautam Gulati

HLTH

Dr. Shepherd on X

Dr. Shepherd on LinkedIn

Dr. Gulati on X

Dr. Gulati on LinkedIn

Resources

Clay Christensen’s Model of Disruptive Innovation

Atomic Habits by James Clear

Wait But Why Blog

Hedge Fund Tips With Tom Hayes - podcast - episode 140 - September 1, 2022